Secondary Malignant Neoplasm — Trials

Secondary Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

14,664 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,270
Recruiting: 2,320
Ph III recruiting: 270
Growth YoY: +13.6%
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,961)

clinicaltrialsPublishedShowing 2,301–2,319 of 2,319 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00162669	Bevacizumab in Advanced Hepatocellular Carcinoma	unknown	Phase 2	50	Gustave Roussy, Cancer Campus, Grand ParisOTHER	1	Sep 8, 2006	clinicaltrials
NCT00356161	HAI Via Interventionally Implanted Port Catheter Systems	unknown	Phase 2	100	Charite University, Berlin, GermanyOTHER	1	Jul 25, 2006	clinicaltrials